Clonazolam 0.6 mg Pellets – Precision Dosed Research Chemical Compound

Introduction to Clonazolam

Clonazolam is a highly potent benzodiazepine analog of the triazolobenzodiazepine class. These 0.6 mg pellets were developed for controlled scientific research into the pharmacological properties of GABA-A receptor modulators. O-DSMT 50 mg Pellets

Product characteristics

• Exact dosage : 0.6 mg per pellet
• Uniform composition : For consistent research results
• Stable matrix formulation : Increased structural integrity
• Batch validation : Each production batch subjected to analytical control

Lyfjafræðilegir eiginleikar

• GABA-A receptor activity : Strong allosteric modulation
• Verkunartími : 6–12 hours (preclinical)
• Anxiolytic, sedative and muscle relaxant profile
• Metabolic half-life : Including active metabolites

Rannsóknarumsóknir

1. GABAergic transmission study
2. Preclinical behavioral models (anxiety, sedation)
3. Potency and structure comparison within benzodiazepines

Tæknilegar upplýsingar

• Shape: round pellets
• Diameter: 2.5mm ± 0.1mm
• Þyngd: 10 mg ± 0,5 mg
• Color: white to light cream. 1V-LSD 150 MCG þynnur

Skammtaleiðbeiningar fyrir rannsóknir

Til vísindalegrar viðmiðunar:

• Í tilraunaglasi : 0.1–1.0 μM
• In vivo preclinical : 0.01–0.1 mg/kg
• Behavioural studies : 0.05–0.3 mg/kg

Öryggisreglur

• Storage: dry and dark at 15–25°C
• Light and moisture sensitive: protectively packaged
• Compatible with common buffers

Skjölun við afhendingu

• Analytical certificate
• Specification file
• Öryggisblað efnis (MSDS)
• Stöðugleikagögn

For research purposes only by qualified professionals. Not for consumption or medical use. Iboga fræ